Pharmacotherapy of obesity: Lessons from clinical trials in hypertension

Journal of Hypertension

Volumn 20, Issue 9, 2002, Pages 1731-1735

  Haynes, William G ^a   Mark, Allyn L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PHENTERMINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

BODY MASS; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; EPIDEMIC; HUMAN; HYPERTENSION; LIFESTYLE; META ANALYSIS; NOTE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0036734130     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200209000-00015     Document Type: Note

References (26)

1. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960-1991
2. The spread of the obesity epidemic in the United States, 1991-1998
3. Body weight and mortality
4. Body weight and mortality among women
5. Weight and blood pressure findings in hypertension screening of 1 million Americans
6. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients
7. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents
8. Obesity and hypertension
9. Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension
10. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
11. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial
12. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
13. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1 -year randomized double-blind study
14. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
15. Long-term weight loss with sibutramine: A randomized controlled trial
16. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus
17. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution
18. Beneficial effects of metformin in normoglycemic morbidly obese adolescents
19. Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial
20. Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mmHg
21. Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg
22. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
23. Adiposity, fat distribution, and cardiovascular risk
24. Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US Army veterans during a 23 year follow-up study
25. Cardiovascular disease risk profiles
26. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)